Daniel H Petroni
Overview
Explore the profile of Daniel H Petroni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim E, Carr W, Assaad A, Gogate S, Petroni D, Casale T, et al.
J Allergy Clin Immunol Glob
. 2025 Feb;
4(1):100382.
PMID: 39896962
Background: Oral immunotherapy is an established approach to desensitize the immune system in the context of allergic disease; however, the only currently approved product is for peanut allergy. ADP101 is...
2.
Chinthrajah R, Sindher S, Nadeau K, Leflein J, Spergel J, Petroni D, et al.
Allergy
. 2024 Dec;
80(3):827-842.
PMID: 39673367
Background: Peanut allergy is a common, life-threatening food allergy in children. We evaluated whether dupilumab, which blocks the activity of interleukin (IL)-4/IL-13, enhances the efficacy of oral immunotherapy (OIT) AR101...
3.
4.
Murphy R, Chow Y, Lai Y, Al-Shaikhly T, Petroni D, Black M, et al.
Allergy
. 2022 Aug;
78(2):547-549.
PMID: 36038252
No abstract available.
5.
Al-Shaikhly T, MacDonald J, Bammler T, Altman M, Ayars A, Petroni D, et al.
Clin Exp Allergy
. 2021 Sep;
51(12):1648-1652.
PMID: 34519110
No abstract available.
6.
Kaminsky L, Aukstuolis K, Petroni D, Al-Shaikhly T
Ann Allergy Asthma Immunol
. 2021 Jun;
127(4):481-487.
PMID: 34175498
Background: Patients with idiopathic anaphylaxis (IA) may fail to respond to a combination of high-dose H and H antihistamines and mast cell stabilizers. Treatment options for these patients are currently...
7.
Vickery B, Vereda A, Nilsson C, Du Toit G, Shreffler W, Burks A, et al.
J Allergy Clin Immunol Pract
. 2020 Dec;
9(5):1879-1889.e13.
PMID: 33359589
Background: The randomized, controlled PALISADE trial demonstrated the benefit of daily oral immunotherapy with Peanut (Arachis Hypogaea) allergen powder-dnfp (PTAH, formerly AR101) in peanut-allergic children and adolescents. Objective: ARC004, the...
8.
Al-Shaikhly T, MacDonald J, Bammler T, Altman M, Ayars A, Petroni D, et al.
Allergy
. 2020 Dec;
76(4):1274-1277.
PMID: 33314187
No abstract available.
9.
Mendoza Alvarez L, Barker R, Nelson C, DiMaggio T, Stone K, Milner J, et al.
Ann Allergy Asthma Immunol
. 2019 Oct;
124(1):99-100.e1.
PMID: 31605754
No abstract available.
10.
Al-Shaikhly T, Rosenthal J, Ayars A, Petroni D
Ann Allergy Asthma Immunol
. 2019 May;
123(2):208-210.e2.
PMID: 31082483
No abstract available.